INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm
NEW YORK, Nov. 14, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose material facts to the U.S. Food and Drug Administration ("FDA") as part of a New Drug Application ("NDA") submission.
On October 27, 2014, Sarepta announced a regulatory update regarding discussions with the FDA related the Company's NDA submission for marketing approval of eteplirsen. According to Sarepta, the FDA provided direction regarding additional and more specific data required from the NDA submission.
Following this news, Sarepta shares declined by $7.65 per share, more than 32%, closing on October 27, 2014 at $15.91 per share.
Request more information now by clicking here: www.faruqilaw.com/SRPT. There is no cost or obligation to you.
Take Action
If you invested in Sarepta stock or options between April 21, 2014 and October 27, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/SRPT. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Sarepta's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
Photo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
SOURCE Faruqi & Faruqi, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article